Compounds > 1,3-dipropylxanthine
Page last updated: 2024-09-05

1,3-dipropylxanthine and n-formylmethionine leucyl-phenylalanine

1,3-dipropylxanthine has been researched along with n-formylmethionine leucyl-phenylalanine in 1 studies

Compound Research Comparison

Studies
(1,3-dipropylxanthine)		Trials
(1,3-dipropylxanthine)		Recent Studies (post-2010)
(1,3-dipropylxanthine)		Studies
(n-formylmethionine leucyl-phenylalanine)		Trials
(n-formylmethionine leucyl-phenylalanine)		Recent Studies (post-2010) (n-formylmethionine leucyl-phenylalanine)
26006,71653356

Protein Interaction Comparison

ProteinTaxonomy1,3-dipropylxanthine (IC50)n-formylmethionine leucyl-phenylalanine (IC50)
fMet-Leu-Phe receptorHomo sapiens (human)0.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ando, M; Furui, H; Hirano, T; Miyamoto, K; Suzuki, K; Takagi, K1

Other Studies

1 other study(ies) available for 1,3-dipropylxanthine and n-formylmethionine leucyl-phenylalanine

ArticleYear
Effect of xanthine derivatives on chemotactic polypeptide-induced superoxide and enzyme release from human polymorphonuclear leucocytes.
    Clinical and experimental pharmacology & physiology, 1993, Volume: 20, Issue:9

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Adenosine Deaminase; Chemotaxis, Leukocyte; Humans; Male; Muramidase; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Purinergic P1 Receptor Antagonists; Superoxides; Xanthines

1993